Ccr7 ligand delivery and co-delivery in immunotherapy
2017
Abstract
Chemokines may be administered to a patient for immunotolerization. Chemokines include CCL19 and CCL21. Materials and methods for accomplishing tolerization and described.
Details
Title
Ccr7 ligand delivery and co-delivery in immunotherapy
Author(s)
Swartz, Melody A ; Hubbell, Jeffrey A ; Tomei, Alice A ; Shields, Jacqueline D ; Kourtis, Iraklis
Date
2017
Keywords
Note
Alternative title(s) :
(de) Ccr7-liganden-verabreichung und co-verabreichung in einer immuntherapie
(fr) Administration et co-administration de ligands de ccr7 en immunothérapie
Other identifier(s)
EPO Family ID: 44368436
Patent number(s)
EP2547328 (B1)
EP2547328 (A4)
US8592364 (B2)
EP2547328 (A2)
WO2011100460 (A3)
US2011206759 (A1)
WO2011100460 (A2)
EP2547328 (A4)
US8592364 (B2)
EP2547328 (A2)
WO2011100460 (A3)
US2011206759 (A1)
WO2011100460 (A2)
Record Appears in
Scientific production and competences > SB - School of Basic Sciences > SB Archives > LMRP - Regenerative Medicine and Pharmacobiology Laboratory
Scientific production and competences > SV - School of Life Sciences > SV Archives > LMRP - Regenerative Medicine and Pharmacobiology Laboratory
Scientific production and competences > Non-academic units > TTO - Technology Transfer Office
Work produced at EPFL
Patents
Scientific production and competences > SV - School of Life Sciences > SV Archives > LMRP - Regenerative Medicine and Pharmacobiology Laboratory
Scientific production and competences > Non-academic units > TTO - Technology Transfer Office
Work produced at EPFL
Patents
Record creation date
2017-06-13